Document is current
Any future updates will be listed below
-
Authors
Sabol, Hayley M.
Galluzzi, Lorenzo
Borriello, Lucia
- License Information
-
More Information
Article History
Received: 20 November 2025
Revised: 2 December 2025
Accepted: 3 December 2025
First Online: 2 January 2026
Competing interests
: L.G. held research contracts with Lytix Biopharma, Promontory, and Onxeo; received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation; and holds Promontory stock options. H.M.S. and L.B. have no conflicts of interest to declare.
